Sign up to save your podcasts
Or
Share PCSK9 Therapy in Diabetes: New Context
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
PCSK9 Therapy in Diabetes: New Context
Dr Robert Eckel reviews research from ADA 2017 on alirocumab in patients with diabetes and mixed dyslipidemia.
View all episodes
By MedscapeDr Robert Eckel reviews research from ADA 2017 on alirocumab in patients with diabetes and mixed dyslipidemia.